Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Fetal lung maturity assessment; lecithin sphingomyelin (L/S) ratio

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

A fetal lung maturity assessment is a critical test conducted to evaluate the development of a fetus's lungs prior to delivery. This assessment specifically utilizes the lecithin sphingomyelin (L/S) ratio, which is derived from an analysis of amniotic fluid. The primary purpose of this test is to assess lung maturity and to estimate the likelihood of the newborn developing respiratory distress syndrome (RDS), also known as hyaline membrane disease, after birth. The L/S ratio provides valuable information that can influence clinical decisions regarding the management of premature labor. If the test indicates that the fetal lungs are not yet mature, healthcare providers may consider interventions to suppress premature labor. Conversely, if the lungs are deemed mature enough, it may be appropriate to allow labor to progress or to induce labor in cases where the mother's or fetus's health is compromised. The assessment involves obtaining a sample of amniotic fluid, which is then analyzed to determine the L/S ratio. Lecithin, a component of pulmonary surfactant, increases in concentration as the fetus's lungs mature, while sphingomyelin, a non-pulmonary lipid, remains relatively stable in the amniotic fluid. The resulting L/S ratio is expressed numerically, with ratios greater than 2 indicating a lower risk of RDS, thereby guiding clinical decisions regarding delivery and neonatal care.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The fetal lung maturity assessment using the lecithin sphingomyelin (L/S) ratio is indicated in several clinical scenarios, particularly when there is a concern regarding the maturity of the fetus's lungs. The following are the specific indications for performing this test:

  • Assessment of Lung Maturity: To evaluate the maturity of the fetal lungs before delivery, particularly in cases of anticipated preterm birth.
  • Risk of Neonatal Respiratory Distress Syndrome (RDS): To determine the probability of the newborn developing RDS, also known as hyaline membrane disease, after delivery.
  • Management of Premature Labor: To decide whether to suppress premature labor based on the maturity of the fetal lungs.
  • Induction of Labor: To assess whether the fetal lungs are mature enough to allow for the induction of labor in patients with complications affecting the health of the mother and/or fetus.

2. Procedure

The procedure for conducting a fetal lung maturity assessment via the lecithin sphingomyelin (L/S) ratio involves several key steps, each critical to obtaining accurate results:

  • Step 1: Amniotic Fluid Sample Collection A separately reportable sample of amniotic fluid is obtained from the patient. This is typically done through an amniocentesis procedure, where a thin needle is inserted through the abdominal wall into the uterus to collect the fluid surrounding the fetus.
  • Step 2: Laboratory Analysis The collected amniotic fluid sample is sent to a laboratory for analysis. In the lab, the amount of lecithin and sphingomyelin in the fluid is measured. Lecithin is a component of pulmonary surfactant, while sphingomyelin is a non-pulmonary lipid that remains constant in concentration.
  • Step 3: Calculation of L/S Ratio The laboratory performs thin layer chromatography to determine the L/S ratio. This involves comparing the levels of lecithin to sphingomyelin in the amniotic fluid. The result is expressed as a numerical ratio, which is crucial for interpreting lung maturity.

3. Post-Procedure

After the fetal lung maturity assessment is completed, the results of the L/S ratio are typically communicated to the healthcare provider. Based on the findings, further clinical decisions can be made regarding the management of the pregnancy. If the L/S ratio indicates that the fetal lungs are mature (greater than 2), the healthcare team may proceed with plans for delivery. Conversely, if the ratio suggests immaturity, additional monitoring and potential interventions to delay delivery may be considered. It is also important to monitor the patient for any complications following the amniocentesis procedure, such as infection or premature rupture of membranes.

Short Descr L/S RATIO FETAL LUNG
Medium Descr FETAL LUNG MATURITY LECITHIN SPHINGOMYELIN RATIO
Long Descr Fetal lung maturity assessment; lecithin sphingomyelin (L/S) ratio
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 3
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
LT Left side (used to identify procedures performed on the left side of the body)
QW Clia waived test
Date
Action
Notes
2011-01-01 Changed Short description changed.
2001-01-01 Changed Code description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"